Table 1.
Characteristics of the patients
| Characteristic | Neoadjuvant chemotherapy (n = 26) |
Primary surgery (n = 26) |
P |
|---|---|---|---|
| Median age (y, range) | 62 (21 – 88) | 60 (26 – 81) | NS |
| Median parity (range) | 1 (0 – 7) | 1 (0 – 4) | NS |
| Median BMI * (range) | 24 (19 – 31) | 22 (16 – 30) | 0.048 |
| BMI ≥ 30 (%) | 2 (8) | 2 (8) | NS |
| Post-menopausal (%) | 21 (81) | 22 (85) | NS |
| Cancer history ** (%) | |||
| Familial | 6 (23) | 10 (38) | NS |
| Personal | 0 | 2 (8) | |
| Familial and personal | 2 (8) | 1 (4) | |
| None | 18 (69) | 13 (50) | |
| Stage (%) | |||
| IIIB | 1 (4) | 3 (12) | 0.045 |
| IIIC | 20 (77) | 23 (88) | |
| IV | 5 (19) | 0 | |
| Histology (%) | |||
| Serous | 16 (61) | 14 (54) | NS |
| Mucinous | 1 (4) | 0 | |
| Endometrioid | 6 (23) | 7 (27) | |
| Clear cells | 0 | 4 (15) | |
| Undifferentiated | 2 (8) | 1 (4) | |
| Other | 1 (4) | 0 | |
| Grade (%) | |||
| 1 | 2 (8) | 4 (16) | NS |
| 2 | 13 (50) | 11 (42) | |
| 3 | 9 (34) | 11 (42) | |
| Unknown | 2 (8) | 0 | |
| Emboli (%) | 6 (23) | 7 (27) | NS |
| Pleural effusion (%) | 3 (12) | 0 | NS |
| Pre-operative CA125 (%) | |||
| ≤ 500 U/ml | 8 (31) | 16 (61) | 0.026 |
| > 500 U/ml | 18 (69) | 10 (39) |
* BMI: Body mass index; ** Only breast, uterus, ovarian and colon cancer were considered.